Pellitteri Phillip K, Ferlito Alfio, Fagan Johannes J, Suárez Carlos, Devaney Kenneth O, Rinaldo Alessandra
Department of Otolaryngology-Head and Neck Surgery, Geisinger Medical Center, Danville, PA, USA.
Oral Oncol. 2007 Nov;43(10):970-5. doi: 10.1016/j.oraloncology.2007.04.007. Epub 2007 Aug 6.
Mesenchymal chondrosarcoma of the head and neck is an uncommon tumor with a potential for exhibiting highly aggressive behavior. When these tumors arise in the head and neck region, they appear to have a predilection for the maxillofacial skeleton; less often, they may involve other soft tissue sites in the head and neck. The diagnosis is challenging and may be assisted by molecular pathologic techniques when only limited tissue is available for analysis. Management is primarily surgical. Although adjuvant radiation appears to convey some benefit by reducing tumor bulk when these lesions have extended beyond bony confines, there is no evidence to suggest that this is associated with improved outcome. Chemotherapy does not appear to be effective in the limited experience documented thus far. Patients with complete local control following resection should be followed closely for development of distant metastasis, which signifies a worse clinical outcome. Future effective therapy may be found in the identification of molecular targets responsive to adjuvant chemotherapy or biologic modifiers.
头颈部间叶性软骨肉瘤是一种罕见肿瘤,具有表现出高度侵袭性行为的可能性。当这些肿瘤发生于头颈部区域时,它们似乎更倾向于累及颌面骨骼;较少见的情况下,它们可能累及头颈部的其他软组织部位。诊断具有挑战性,当仅有有限的组织可用于分析时,分子病理技术可能有助于诊断。治疗主要是手术治疗。尽管当这些病变超出骨边界时,辅助放疗似乎通过减少肿瘤体积带来一些益处,但没有证据表明这与改善预后相关。根据目前有限的经验,化疗似乎无效。切除术后实现局部完全控制的患者应密切随访,观察是否发生远处转移,远处转移意味着临床预后更差。未来可能通过识别对辅助化疗或生物调节剂有反应的分子靶点找到有效的治疗方法。